Bass KE - Search Results

1

An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.

Falgueyret JP, Black WC, Cromlish W, Desmarais S, Lamontagne S, Mellon C, Riendeau D, Rodan S, Tawa P, Wesolowski G, Bass KE, Venkatraman S, Percival MD. Falgueyret JP, et al. Among authors: bass ke. Anal Biochem. 2004 Dec 15;335(2):218-27. doi: 10.1016/j.ab.2004.09.005. Anal Biochem. 2004. PMID: 15556560

2

Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors.

Rydzewski RM, Bryant C, Oballa R, Wesolowski G, Rodan SB, Bass KE, Wong DH. Rydzewski RM, et al. Among authors: bass ke. Bioorg Med Chem. 2002 Oct;10(10):3277-84. doi: 10.1016/s0968-0896(02)00173-6. Bioorg Med Chem. 2002. PMID: 12150873

3

Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.

Rydzewski RM, Burrill L, Mendonca R, Palmer JT, Rice M, Tahilramani R, Bass KE, Leung L, Gjerstad E, Janc JW, Pan L. Rydzewski RM, et al. Among authors: bass ke. J Med Chem. 2006 May 18;49(10):2953-68. doi: 10.1021/jm058289o. J Med Chem. 2006. PMID: 16686537

4

Mouse ornithine decarboxylase is stable in Trypanosoma brucei.

Bass KE, Sommer JM, Cheng QL, Wang CC. Bass KE, et al. J Biol Chem. 1992 Jun 5;267(16):11034-7. J Biol Chem. 1992. PMID: 1597444 Free article.

5

CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo.

Buggy JJ, Cao ZA, Bass KE, Verner E, Balasubramanian S, Liu L, Schultz BE, Young PR, Dalrymple SA. Buggy JJ, et al. Among authors: bass ke. Mol Cancer Ther. 2006 May;5(5):1309-17. doi: 10.1158/1535-7163.MCT-05-0442. Mol Cancer Ther. 2006. PMID: 16731764

6

CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo.

Cao ZA, Bass KE, Balasubramanian S, Liu L, Schultz B, Verner E, Dai Y, Molina RA, Davis JR, Misialek S, Sendzik M, Orr CJ, Leung L, Callan O, Young P, Dalrymple SA, Buggy JJ. Cao ZA, et al. Among authors: bass ke. Mol Cancer Ther. 2006 Jul;5(7):1693-701. doi: 10.1158/1535-7163.MCT-06-0042. Mol Cancer Ther. 2006. PMID: 16891455

7

The translation initiation site of recombinant Trypanosoma brucei ornithine decarboxylase varies with different promoters.

Kuntz DA, Phillips MA, Moore TD, Craig SP 3rd, Bass KE, Wang CC. Kuntz DA, et al. Among authors: bass ke. Mol Biochem Parasitol. 1992 Oct;55(1-2):95-104. doi: 10.1016/0166-6851(92)90130-c. Mol Biochem Parasitol. 1992. PMID: 1435879

8

Transient inhibition of protein synthesis accompanies differentiation of Trypanosoma brucei from bloodstream to procyclic forms.

Bass KE, Wang CC. Bass KE, et al. Mol Biochem Parasitol. 1992 Nov;56(1):129-40. doi: 10.1016/0166-6851(92)90160-l. Mol Biochem Parasitol. 1992. PMID: 1474991

9

The in vitro differentiation of pleomorphic Trypanosoma brucei from bloodstream into procyclic form requires neither intermediary nor short-stumpy stage.

Bass KE, Wang CC. Bass KE, et al. Mol Biochem Parasitol. 1991 Feb;44(2):261-70. doi: 10.1016/0166-6851(91)90012-u. Mol Biochem Parasitol. 1991. PMID: 2052026

10

Trypanosome ornithine decarboxylase is stable because it lacks sequences found in the carboxyl terminus of the mouse enzyme which target the latter for intracellular degradation.

Ghoda L, Phillips MA, Bass KE, Wang CC, Coffino P. Ghoda L, et al. Among authors: bass ke. J Biol Chem. 1990 Jul 15;265(20):11823-6. J Biol Chem. 1990. PMID: 2365702 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page